{"entity":{"type":"insider","cik":"0001827169","url":"/insider/0001827169","json_url":"/insider/0001827169.json","name":"Ryan Barbara","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2022-06-03","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Ryan Barbara","source":"filing","n_filings":7,"first_seen":"2022-06-03","last_seen":"2026-06-05"}],"transactions":[{"id":6196409,"accession":"0001193125-26-260084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-260084","line_url":"/filing/0001193125-26-260084","is_derivative":false,"issuer_cik":"0001827169","issuer_name":"MiNK Therapeutics, Inc.","issuer_ticker":"INKT","issuer_name_source":null,"issuer_url":"/issuer/0001827169","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":12.760833333333334,"price_display":"12.76","price_state":"stated","total_value":19141.25,"total_display":"19,141.25","total_whole":"19,141","shares_owned_after":21969.0,"shares_owned_after_display":"21,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-05","scope":"insider","n_lines":2},{"id":5759181,"accession":"0001827169-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827169-26-000010","line_url":"/filing/0001827169-26-000010#line-1","is_derivative":false,"issuer_cik":"0001625297","issuer_name":"Indivior Pharmaceuticals, Inc.","issuer_ticker":"INDV","issuer_name_source":null,"issuer_url":"/issuer/0001625297","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8.0,"shares_display":"8","price_per_share":31.085,"price_display":"31.08","price_state":"stated","total_value":248.68,"total_display":"248.68","total_whole":"249","shares_owned_after":5724.0,"shares_owned_after_display":"5,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-13","scope":"insider"},{"id":5904962,"accession":"0001193125-26-102581","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-102581","line_url":"/filing/0001193125-26-102581","is_derivative":false,"issuer_cik":"0001827169","issuer_name":"MiNK Therapeutics, Inc.","issuer_ticker":"INKT","issuer_name_source":null,"issuer_url":"/issuer/0001827169","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":15.397892307692308,"price_display":"15.40","price_state":"stated","total_value":20017.26,"total_display":"20,017.26","total_whole":"20,017","shares_owned_after":20906.0,"shares_owned_after_display":"20,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider","n_lines":3},{"id":5904956,"accession":"0001193125-26-102581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-102581","line_url":"/filing/0001193125-26-102581#line-1","is_derivative":false,"issuer_cik":"0001827169","issuer_name":"MiNK Therapeutics, Inc.","issuer_ticker":"INKT","issuer_name_source":null,"issuer_url":"/issuer/0001827169","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":10.1725,"price_display":"10.17","price_state":"stated","total_value":2034.5,"total_display":"2,034.50","total_whole":"2,035","shares_owned_after":21706.0,"shares_owned_after_display":"21,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":5771540,"accession":"0001827169-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827169-26-000008","line_url":"/filing/0001827169-26-000008#line-1","is_derivative":false,"issuer_cik":"0001625297","issuer_name":"Indivior Pharmaceuticals, Inc.","issuer_ticker":"INDV","issuer_name_source":null,"issuer_url":"/issuer/0001625297","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31.0,"shares_display":"31","price_per_share":32.56,"price_display":"32.56","price_state":"stated","total_value":1009.36,"total_display":"1,009.36","total_whole":"1,009","shares_owned_after":5716.0,"shares_owned_after_display":"5,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":5749079,"accession":"0001193125-26-091707","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-091707","line_url":"/filing/0001193125-26-091707#line-2","is_derivative":false,"issuer_cik":"0001827169","issuer_name":"MiNK Therapeutics, Inc.","issuer_ticker":"INKT","issuer_name_source":null,"issuer_url":"/issuer/0001827169","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":10.8258,"price_display":"10.83","price_state":"stated","total_value":1082.58,"total_display":"1,082.58","total_whole":"1,083","shares_owned_after":21906.0,"shares_owned_after_display":"21,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5749077,"accession":"0001193125-26-091707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-091707","line_url":"/filing/0001193125-26-091707#line-1","is_derivative":false,"issuer_cik":"0001827169","issuer_name":"MiNK Therapeutics, Inc.","issuer_ticker":"INKT","issuer_name_source":null,"issuer_url":"/issuer/0001827169","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":10.8583,"price_display":"10.86","price_state":"stated","total_value":4343.32,"total_display":"4,343.32","total_whole":"4,343","shares_owned_after":22006.0,"shares_owned_after_display":"22,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-04","scope":"insider"},{"id":5900123,"accession":"0001827169-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827169-26-000004","line_url":"/filing/0001827169-26-000004#line-1","is_derivative":false,"issuer_cik":"0001625297","issuer_name":"INDIVIOR PLC","issuer_ticker":"INDV","issuer_name_source":null,"issuer_url":"/issuer/0001625297","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":775.0,"shares_display":"775","price_per_share":35.3926,"price_display":"35.39","price_state":"stated","total_value":27429.265,"total_display":"27,429.26","total_whole":"27,429","shares_owned_after":1963.0,"shares_owned_after_display":"1,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":6602061,"accession":"0001493152-22-015911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-015911","line_url":"/filing/0001493152-22-015911#line-1","is_derivative":false,"issuer_cik":"0001417926","issuer_name":"INVO Bioscience, Inc.","issuer_ticker":"INVO","issuer_name_source":null,"issuer_url":"/issuer/0001417926","owner_cik":"0001827169","owner_name":"Ryan Barbara","owner_display_name":"Ryan Barbara","owner_url":"/insider/0001827169","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10526.0,"shares_display":"10,526","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":9999.7,"total_display":"9,999.70","total_whole":"10,000","shares_owned_after":22991.0,"shares_owned_after_display":"22,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840229","name":"MiNK Therapeutics, Inc.","url":"/issuer/0001840229","role":"Director","n_filings":3,"first_seen":"2026-03-04","last_seen":"2026-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001625297","name":"Indivior Pharmaceuticals, Inc.","url":"/issuer/0001625297","role":"Director","n_filings":3,"first_seen":"2026-01-07","last_seen":"2026-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001417926","name":"INVO Bioscience, Inc.","url":"/issuer/0001417926","role":"Director","n_filings":1,"first_seen":"2022-06-03","last_seen":"2022-06-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001827169","retrieved_at":"2026-08-23T18:55:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}